These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 29960150

  • 1. Synthesis and biological characterization of organoruthenium complexes with 8-hydroxyquinolines.
    Kljun J, León IE, Peršič Š, Cadavid-Vargas JF, Etcheverry SB, He W, Bai Y, Turel I.
    J Inorg Biochem; 2018 Sep; 186():187-196. PubMed ID: 29960150
    [Abstract] [Full Text] [Related]

  • 2. Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer.
    Ruiz MC, Kljun J, Turel I, Di Virgilio AL, León IE.
    Metallomics; 2019 Mar 20; 11(3):666-675. PubMed ID: 30839008
    [Abstract] [Full Text] [Related]

  • 3. Comparative solution equilibrium studies of antitumor ruthenium(η6-p-cymene) and rhodium(η5-C5Me5) complexes of 8-hydroxyquinolines.
    Dömötör O, Pape VFS, May NV, Szakács G, Enyedy ÉA.
    Dalton Trans; 2017 Mar 27; 46(13):4382-4396. PubMed ID: 28287667
    [Abstract] [Full Text] [Related]

  • 4. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties.
    Mu C, Prosser KE, Harrypersad S, MacNeil GA, Panchmatia R, Thompson JR, Sinha S, Warren JJ, Walsby CJ.
    Inorg Chem; 2018 Dec 17; 57(24):15247-15261. PubMed ID: 30495936
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines.
    Havrylyuk D, Howerton BS, Nease L, Parkin S, Heidary DK, Glazer EC.
    Eur J Med Chem; 2018 Aug 05; 156():790-799. PubMed ID: 30055464
    [Abstract] [Full Text] [Related]

  • 6. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
    Rahman FU, Bhatti MZ, Ali A, Duong HQ, Zhang Y, Ji X, Lin Y, Wang H, Li ZT, Zhang DW.
    Eur J Med Chem; 2018 Sep 05; 157():1480-1490. PubMed ID: 30282320
    [Abstract] [Full Text] [Related]

  • 7. Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug development.
    Babak MV, Meier SM, Legin AA, Adib Razavi MS, Roller A, Jakupec MA, Keppler BK, Hartinger CG.
    Chemistry; 2013 Mar 25; 19(13):4308-18. PubMed ID: 23341078
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR, Nongbri SL, Premkumar JR, Verma AK, Bhattacharjee K, Joshi SR, Forbes S, Mozharivskyj Y, Thounaojam R, Aguan K, Kollipara MR.
    J Biol Inorg Chem; 2015 Jun 25; 20(4):619-38. PubMed ID: 25712889
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity of organoruthenium complexes with chelate aromatic ligands, derived from 1,10-phenantroline: Synthesis and biological activity.
    Savić A, Gligorijević N, Aranđelović S, Dojčinović B, Kaczmarek AM, Radulović S, Van Deun R, Van Hecke K.
    J Inorg Biochem; 2020 Jan 25; 202():110869. PubMed ID: 31669694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y, Zheng W, Luo Q, Zhao Y, Zhang E, Liu S, Wang F.
    Dalton Trans; 2015 Aug 07; 44(29):13100-11. PubMed ID: 26106875
    [Abstract] [Full Text] [Related]

  • 15. Making organoruthenium complexes of 8-hydroxyquinolines more hydrophilic: impact of a novel l-phenylalanine-derived arene ligand on the biological activity.
    Movassaghi S, Hanif M, Holtkamp HU, Söhnel T, Jamieson SMF, Hartinger CG.
    Dalton Trans; 2018 Feb 13; 47(7):2192-2201. PubMed ID: 29359219
    [Abstract] [Full Text] [Related]

  • 16. Design of Ru-arene Complexes for Antitumor Drugs.
    Su W, Li Y, Li P.
    Mini Rev Med Chem; 2018 Feb 13; 18(2):184-193. PubMed ID: 28494728
    [Abstract] [Full Text] [Related]

  • 17. Coordination Chemistry of Organoruthenium Compounds with Benzoylthiourea Ligands and their Biological Properties.
    Parveen S, Tong KKH, Khawar Rauf M, Kubanik M, Shaheen MA, Söhnel T, Jamieson SMF, Hanif M, Hartinger CG.
    Chem Asian J; 2019 Apr 15; 14(8):1262-1270. PubMed ID: 30706633
    [Abstract] [Full Text] [Related]

  • 18. Novel mitochondria targeted copper(ii) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity.
    Deka B, Sarkar T, Banerjee S, Kumar A, Mukherjee S, Deka S, Saikia KK, Hussain A.
    Dalton Trans; 2017 Jan 03; 46(2):396-409. PubMed ID: 27929173
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells.
    Ballester FJ, Ortega E, Porto V, Kostrhunova H, Davila-Ferreira N, Bautista D, Brabec V, Domínguez F, Santana MD, Ruiz J.
    Chem Commun (Camb); 2019 Jan 25; 55(8):1140-1143. PubMed ID: 30631876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.